SC-560 is primarily used in research settings as a selective inhibitor of cyclooxygenase-1 (COX-1). It is often employed in studies to understand the role of COX-1 in various physiological and pathological processes, such as inflammation, pain, and fever. By specifically blocking COX-1, researchers can differentiate its effects from those of COX-2, providing insights into the mechanisms of action of nonsteroidal anti-inflammatory drugs (NSAIDs). Additionally, SC-560 is utilized in experiments to investigate the involvement of COX-1 in gastrointestinal protection, platelet aggregation, and cardiovascular function. Its selective inhibition helps in developing targeted therapies for conditions where COX-1 activity is implicated.